Trial · NCT03941834
Participant flow39
How many started, completed or left each group, period by period.
1 to 20 of 39
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| DBT Phase: 1st Treatment Period (2Weeks) | STARTED | DBT Phase: Placebo Then Rimegepant (BHV-3000) | 15 | |
| DBT Phase: 1st Treatment Period (2Weeks) | STARTED | DBT Phase: Rimegepant Then Placebo | 15 | |
| DBT Phase: 1st Treatment Period (2Weeks) | STARTED | OLE Phase: Rimegepant | 0 | |
| DBT Phase: 1st Treatment Period (2Weeks) | Treated | DBT Phase: Placebo Then Rimegepant (BHV-3000) | 15 | |
| DBT Phase: 1st Treatment Period (2Weeks) | Treated | DBT Phase: Rimegepant Then Placebo | 14 | |
| DBT Phase: 1st Treatment Period (2Weeks) | Treated | OLE Phase: Rimegepant | 0 | |
| DBT Phase: 1st Treatment Period (2Weeks) | COMPLETED | DBT Phase: Placebo Then Rimegepant (BHV-3000) | 14 | |
| DBT Phase: 1st Treatment Period (2Weeks) | COMPLETED | DBT Phase: Rimegepant Then Placebo | 14 | |
| DBT Phase: 1st Treatment Period (2Weeks) | COMPLETED | OLE Phase: Rimegepant | 0 | |
| DBT Phase: 1st Treatment Period (2Weeks) | NOT COMPLETED | DBT Phase: Placebo Then Rimegepant (BHV-3000) | 1 | |
| DBT Phase: 1st Treatment Period (2Weeks) | NOT COMPLETED | DBT Phase: Rimegepant Then Placebo | 1 | |
| DBT Phase: 1st Treatment Period (2Weeks) | NOT COMPLETED | OLE Phase: Rimegepant | 0 | |
| DBT Phase: Washout Period (7 Days) | STARTED | DBT Phase: Placebo Then Rimegepant (BHV-3000) | 14 | |
| DBT Phase: Washout Period (7 Days) | STARTED | DBT Phase: Rimegepant Then Placebo | 14 | |
| DBT Phase: Washout Period (7 Days) | STARTED | OLE Phase: Rimegepant | 0 | |
| DBT Phase: Washout Period (7 Days) | COMPLETED | DBT Phase: Placebo Then Rimegepant (BHV-3000) | 14 | |
| DBT Phase: Washout Period (7 Days) | COMPLETED | DBT Phase: Rimegepant Then Placebo | 14 | |
| DBT Phase: Washout Period (7 Days) | COMPLETED | OLE Phase: Rimegepant | 0 | |
| DBT Phase: Washout Period (7 Days) | NOT COMPLETED | DBT Phase: Placebo Then Rimegepant (BHV-3000) | 0 | |
| DBT Phase: Washout Period (7 Days) | NOT COMPLETED | DBT Phase: Rimegepant Then Placebo | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03941834/flow